Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
01/2009
01/08/2009US20090011468 Method for improving protein production
01/08/2009US20090011467 Novel fructosyl peptide oxidase
01/08/2009US20090011465 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells
01/08/2009US20090011464 Humanized immunoglubulin reactive with alph4beta7 integrin
01/08/2009US20090011460 Calcium-binding photoprotein, gene encoding the same, and use thereof
01/08/2009US20090011442 TB diagnostics based on mycobacterium tuberculosis excretory secretory antigens and their specific immunoglobulins
01/08/2009US20090011419 Probe, probe set, probe carrier, and testing method
01/08/2009US20090011417 Testing Device
01/08/2009US20090011413 Method for screening colon cancer cells and gene set used for examination of colon cancer
01/08/2009US20090011411 Method for Detecting and Quantifying Endogenous Wheat Dna Sequence
01/08/2009US20090011407 Polymorphic Cd24 Genotypes that are Predictive of Multiple Sclerosis Risk and Progression
01/08/2009US20090011080 Gene encoding protein responsible for flocculation property of yeast and use thereof
01/08/2009US20090010961 Avirulent, immunogenic flavivirus chimeras
01/08/2009US20090010956 Ehrlichia ewingii proteins, nucleic acids, and methods of their use
01/08/2009US20090010938 Short immunomodulatory oligonucleotides
01/08/2009US20090010933 inhibiting vascularization or angiogenesis using chimeric proteins, immunoglobulin-like domains of tyrosine kinase receptors
01/08/2009US20090010930 Antibodies to vla-1
01/08/2009US20090010924 Apoptotic Anti-IgE Antibodies
01/08/2009US20090010921 Antigen binding molecules with increased Fc receptor binding affinity and effector function
01/08/2009US20090010917 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor
01/08/2009US20090010879 Receptor Based Antagonists and Methods of Making and Using
01/08/2009US20090010875 IL-7 Fusion Proteins
01/08/2009US20090010848 Recombinant Peptides Derived from the Mc3 Anti-BA46 Antibody, Methods of Use Thereof, and Methods of Humanizing Antibody Peptides
01/08/2009US20090010847 Connective Tissue Growth Factor-4
01/08/2009US20090010842 Methods for the early diagnosis of ovarian cancer
01/08/2009CA2707436A1 Copy dna and sense rna
01/08/2009CA2692603A1 Peptides facilitating retrograde transport and their uses
01/08/2009CA2692579A1 6-disubstituted bicyclic nucleic acid analogs
01/08/2009CA2692503A1 Dsrna for treating viral infection
01/07/2009EP2012124A2 Method for immuno-detection of epitopes on molecules and for detection of interactions of molecules via fluorescent dyes
01/07/2009EP2011888A1 Nucleotide sequences resulting from the genome of the HIV-1, HIV-2 and SIV retroviruses, and their applications in particular for amplifying the genomes of these retroviruses and for in vitro diagnosis of infections caused by these viruses
01/07/2009EP2011873A2 Tumor necrosis factor receptor-associated factors
01/07/2009EP2011503A2 High affinity nucleic acid ligands of cytokines
01/07/2009EP2011068A2 Methylation of genes as a predictor of polyp formation and recurrence
01/07/2009EP2010675A2 New detector probe acting by molecular recognition
01/07/2009EP2010650A2 Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors
01/07/2009EP2010554A2 Mig-7 as a specific anticancer target
01/07/2009EP2010225A2 Methods and compositions for targeting c-rel
01/07/2009EP2010224A2 Method and composition for treating and preventing tumor metastasis in vivo
01/07/2009EP2009990A2 Methods and compositions related to adenoassociated virus-phage particles
01/07/2009EP1877417A4 Ubiquilin regulation of presenilin endoproteolysis, and suppression of polyglutamine-induced toxicity in cells
01/07/2009EP1799860A4 Dna fingerprinting using a branch migration assay
01/07/2009EP1794173A4 Amplification blocker comprising intercalating nucleic acids (tna) containing intercalating pseudonucleotides (ipn)
01/07/2009EP1791981A4 Methods of using sulfur nucleophiles as improved alternatives to sodium bisulfite for methylated dna analysis
01/07/2009EP1740600A4 Intracellular delivery of osteoinductive proteins and peptides
01/07/2009EP1711614B1 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use
01/07/2009EP1540006B1 Nanoparticle polyanion conjugates and methods of use thereof in detecting analytes
01/07/2009EP1532239B1 Methods and compositions for targeting secretory lysosomes
01/07/2009EP1474434B1 The eaat2 promoter and uses thereof
01/07/2009EP1442045B1 Isolation and purification of nucleic acids
01/07/2009EP1440311B1 Affinity-shifted probes for quantifying analyte polynucleotides
01/07/2009EP1407046B1 Method of dna sequencing using cleavable tags
01/07/2009EP1263987B1 Random truncation and amplification of nucleic acid
01/07/2009EP1255716B1 Segment synthesis
01/07/2009EP0833944B1 Nucleic acid ligands that bind to and inhibit dna polymerases
01/07/2009EP0662827B2 Diagnostic methods and pharmaceutical compositions based on notch proteins and nucleic acids
01/07/2009CN101341258A Single step detection assay
01/07/2009CN101341257A Human papilloma virus (HPV) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (FACS)
01/07/2009CN101340814A Methods to produce desired proteins in plants
01/07/2009CN100448993C Interferon-like protein zcyto 21
01/06/2009US7473820 Flax (Linum usitatissimum L.) seed-specific promoters
01/06/2009US7473775 Abortive promoter cassettes
01/06/2009US7473774 Kit for diagnosing and prognosticating matrix metalloproteinase-1 related disease via a matrix metalloproteinase-1 single nucleotide polymorphism
01/06/2009US7473773 Determination of hepatitis C virus genotype
01/06/2009US7473772 Chimeric GB virus B (GBV-B)
01/06/2009US7473770 Indentifying analytes which interfere with the interaction between the cDkk-4 protein and a homologous or heterologous Dkk receptor; useful for treating osteoporosis and other bone loss disorders.
01/06/2009US7473769 Produced from Polypedilum vanderplanki larvae; introduction of these genes into animal cells successfully conferred desiccation resistance to the cells.
01/06/2009US7473768 Primers and a screening method for identification of artemisinin producing plants
01/06/2009US7473767 Methods for detection and quantification of analytes in complex mixtures
01/06/2009US7473765 Cytokine zalpha11 ligand
01/06/2009US7473763 Encoded by the full-length coding sequence of the complementary DNA deposited under ATCC accession number PTA-2591; may be fused to a heterologous polypeptide; an epitope tag or an Fc region of an immunoglobulin; diagnosis or treatment of immune related diseases
01/06/2009US7473733 Cationic derivative of a water-soluble polysaccharide, cationic polyvinylalcohol, units derived from acrylic ester complexed with DNA; stable and soap-less latex; useful as a micro carrier for cell cultivation and immuno-adsorbent assay, gene transfer experiments, efficiency, transfection
01/06/2009US7473554 Polynucleotides encoding novel Bt toxin receptors from lepidopteran insects
01/06/2009US7473553 Isolated nucleic acid; insecticides
01/06/2009US7473547 Test piece, method of and apparatus for manufacturing the test piece and method of and system for reading the same
01/06/2009US7473545 Acidovorax facilis 72W nitrilase mutants having improved nitrilase activity for converting glycolonitrile to glycolic acid; 1.5 to 4-fold increase in activity, while maintaining identical reaction conditions
01/06/2009US7473542 Therapeutic bioactive ribonucleases for use in the tissue targeted therapy against tumors; tumor cytotoxic factors; antitumor agents
01/06/2009US7473526 Prognosticating metastasis in a breast cancer patient by identifying differential modulation of each gene selected from a group; gene expression portfolios and kits
01/06/2009US7473525 Rna; anticancer agents
01/06/2009US7473418 Pan cancer oncolytic vectors and methods of use thereof
01/06/2009CA2179603C Production of pharmaceutical-grade plasmid dna
01/06/2009CA2158446C Nucleic acid coding for a tumor rejection antigen precursor
01/06/2009CA2154628C Xylanase, microorganisms producing the same, dna molecules, process for preparing said xylanase and uses thereof
01/06/2009CA2144406C Gene transcription and ionizing radiation: methods and compositions
01/06/2009CA2134357C Nucleic acid probes to mycobacterium tuberculosis
01/06/2009CA2117490C Purified vacuolating toxin from helicobacter pylori and methods to use same
01/01/2009US20090007302 Seed-preferred regulatory element
01/01/2009US20090007296 capable of conferring environmental stress tolerance to plants upon over-expression; genetic engineering
01/01/2009US20090005550 used to produce oligonucleotides in a simple manner which contain modified phosphate residues and thus can also preferably detectable labels; resonance-stabilized and are not susceptible to hydrolysis
01/01/2009US20090005549 Processes and Reagents for Desilylation of Oligonucleotides
01/01/2009US20090005548 Using RNA interference to treat and prevent diabetes, alzheimer's, cancer disorders; antisense agents
01/01/2009US20090005547 siRNa targeting neuropilin 1 (NRP1)
01/01/2009US20090005536 Hybrid solid supports useful for oligonucleotide production
01/01/2009US20090005337 Phosphodiesterases (PDE); used for screening for Cushing's syndrome or bilateral adrenocortical hyperplasia (BAH)
01/01/2009US20090005336 Use of the microRNA miR-1 for the treatment, prevention, and diagnosis of cardiac conditions
01/01/2009US20090005335 Compounds for the modulation of beta-catenin expression
01/01/2009US20090005334 Nucleic acid derivatives
01/01/2009US20090005332 Compositions and Methods for Modulating Gene Expression Using Self-Protected Oligonucleotides
01/01/2009US20090005330 Methods and Compositions to Inhibit P2x7 Receptor Expression
01/01/2009US20090005329 Synthesizing 2'- beta -substituted phosphoramidites with pendent amine and carboxylate groups, oligomerization, coupling the pendent groups to form a nylon-DNA ladder copolymer; DNA nanotechnology; inhibition of antisense agent biosynthesis